Robot maker · early
Autonomyo
EPFL (REHAssist) spin-off developing an AI-assisted lower-limb exoskeleton for people with neuromuscular and motor disorders, actuating hip, knee and ankle while collecting biomechanical data to personalize gait training. Its Skywalk system packages the exoskeleton with a safety frame and digital therapy platform for robot-assisted rehabilitation at home rather than only in clinics. Clinical trials completed at CHUV (Lausanne University Hospital); pursuing CE certification and FDA readiness to enter EU and US markets. Raised EUR 1.4M in November 2025 plus a Capital Cell crowdfunding campaign. Pre-commercial medical device, flagged for curator.
Company overview
Identity and operating footprint
Robot models
Specifications remain vendor-claimed
Skywalk
- AI-assisted lower-limb exoskeleton guiding hip, knee and ankle with biomechanical data-driven personalization
Powered gait exoskeleton integrated with safety frame and digital therapy platform for home rehabilitation
Claim source
Funding history
Publicly announced rounds
Seed
Investors undisclosed
Round sourceCompany timeline
Milestones and announcements
Source ledger
2 unique public sources